Véronique M. C.
- Country
- France
- Department
- ONCOLOGIE
Research Overview
- Phase 1b Open-Label Study of Epcoritamab in Pediatric Patients with Relapsed/Refractory Aggressive Mature B-cell Neoplasms
- Evaluation of Irinotecan, Ifosfamide, Vincristine, and Dactinomycin in Frontline and Relapsed Rhabdomyosarcoma in Pediatric and Adult Populations
- Phase II Evaluation of Safety and Efficacy of Zamtocabtagene Autoleucel in Pediatric Relapsed/Refractory Mature B-Cell Neoplasms with Fludarabine and Cyclophosphamide
Data & Insights
Has run more than one trial at 34 of 177 partner sites.
Specializations
Lymphoma Research
This investigator specializes in treating various forms of B-cell lymphomas and anaplastic large cell lymphoma (ALCL), with particular focus on refractory and relapsed cases. Their expertise extends to innovative immunotherapy approaches and targeted treatments.
- CD20-positive B-Cell Non-Hodgkin Lymphoma
- ALK-positive ALCL
- Aggressive Mature B-cell Neoplasms
Their work encompasses novel therapeutic combinations including chemoimmunotherapy regimens and immunological approaches.
Sarcoma Studies
The investigator conducts comprehensive research in rhabdomyosarcoma treatment, addressing both frontline and relapsed cases. Their work includes investigation of various therapeutic strategies for different risk categories.
- Frontline Rhabdomyosarcoma
- High-Risk RMS
- Very High-Risk RMS
Their research encompasses both systemic therapy approaches and radiotherapy optimization strategies.
Innovative Therapies
The investigator explores cutting-edge treatments including targeted therapies and immunological approaches. Their research portfolio includes evaluation of novel agents such as brigatinib and various immunotherapeutic compounds.
- CAR-T Cell Therapy
- Targeted Molecular Therapies
- Inflammatory Myofibroblastic Tumors
They focus on developing personalized treatment approaches for pediatric and young adult patients with various malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.